NUCLEIC CAPITAL
Specialist biotech fund management
We are a specialist biotechnology investment firm based in the Channel Islands. Our focus is on investing in listed equities globally, targeting opportunities where technology advancements intersect with healthcare and synthetic biology.
OUR INVESTMENT STRATEGY
At Nucleic Capital, we invest in biotechnology companies that have a strong focus on research and development, particularly in the areas of healthcare and synthetic biology. We use our expertise to identify companies that have the potential for long-term growth and profitability.
OUR PHILOSOPHY
We believe that biotechnology has the potential to revolutionize healthcare and improve the lives of people around the world. By investing in companies that are at the forefront of this field, we aim to not only generate returns for our investors but also contribute to the advancement of science and medicine.
OUR COMMITMENT TO SUSTAINABILITY
We are committed to investing in companies that have a positive impact on the environment and society. We prioritize companies that have a focus on sustainability and are working towards reducing their carbon footprint.